These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2877076)

  • 1. ICI 180080, a novel selective thromboxane receptor antagonist: synthesis and relative activity.
    Brown GR; Foubister AJ
    J Pharm Pharmacol; 1986 Sep; 38(9):706-8. PubMed ID: 2877076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved synthetic routes to the novel thromboxane receptor antagonist ICI 192605: activity of synthetic 1,3-dioxane intermediates.
    Brown GR; Foubister AJ; Hudson JA
    J Pharm Pharmacol; 1990 Jan; 42(1):53-5. PubMed ID: 1969951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological actions of ICI 180080, a novel thromboxane receptor antagonist.
    Jessup CL; Jessup R; Wayne M
    J Pharm Pharmacol; 1986 Oct; 38(10):754-7. PubMed ID: 2878996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (5Z)-7-(2,2-Dimethyl-4-phenyl-1,3-dioxan-cis-5-yl)heptenoi c acid: a specific thromboxane A2 receptor antagonist.
    Brewster AG; Caulkett PW; Jessup R
    J Med Chem; 1987 Jan; 30(1):67-70. PubMed ID: 2949077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis of a novel thromboxane receptor antagonist 4(Z)-6-(2-o-chlorophenyl-4-o-hydroxyphenyl-1,3-dioxan-cis-5-yl) hexenoic acid ICI 192605.
    Brewster AG; Brown GR; Foubister AJ; Jessup R; Smithers MJ
    Prostaglandins; 1988 Aug; 36(2):173-8. PubMed ID: 2973084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies in the guinea-pig with ICI 185,282: a thromboxane A2 receptor antagonist.
    Birch J; Brown E; Calnan C; Jessup CL; Jessup R; Wayne M
    J Pharm Pharmacol; 1988 Oct; 40(10):706-10. PubMed ID: 2907537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (+/-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo[2.2.1] hept-2-exo-yl]heptenoic acid.
    Narisada M; Ohtani M; Watanabe F; Uchida K; Arita H; Doteuchi M; Hanasaki K; Kakushi H; Otani K; Hara S
    J Med Chem; 1988 Sep; 31(9):1847-54. PubMed ID: 2970551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.
    Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
    Br J Pharmacol; 1993 Dec; 110(4):1600-6. PubMed ID: 8306107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P; White BP; Humphrey PP
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitor.
    Imura Y; Terashita Z; Shibouta Y; Nishikawa K
    Eur J Pharmacol; 1988 Mar; 147(3):359-65. PubMed ID: 2967770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azulene derivatives: new non-prostanoid thromboxane A2 receptor antagonists.
    Tomiyama T; Wakabayashi S; Kosakai K; Yokota M
    J Med Chem; 1990 Sep; 33(9):2323-6. PubMed ID: 2144025
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel approach to dual-acting thromboxane receptor antagonist/synthase inhibitors based on the link of 1,3-dioxane-thromboxane receptor antagonists and -thromboxane synthase inhibitors.
    Ackerley N; Brewster AG; Brown GR; Clarke DS; Foubister AJ; Griffin SJ; Hudson JA; Smithers MJ; Whittamore PR
    J Med Chem; 1995 May; 38(10):1608-28. PubMed ID: 7752186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoconstrictor effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F(2alpha) on human umbilical vein.
    Daray FM; Minvielle AI; Puppo S; Rothlin RP
    Eur J Pharmacol; 2004 Sep; 499(1-2):189-95. PubMed ID: 15363966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-acting thromboxane receptor antagonist/synthase inhibitors: synthesis and biological properties of [2-substituted-4-(3-pyridyl)-1,3-dioxan-5-yl] alkenoic acids.
    Faull AW; Brewster AG; Brown GR; Smithers MJ; Jackson R
    J Med Chem; 1995 Feb; 38(4):686-94. PubMed ID: 7861416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
    Hussain MB; Marshall I
    Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Action of the novel selective thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid on vascular smooth muscle preparations.
    Perzborn E; Seuter F; Fiedler VB; Rosentreter U; Böshagen H
    Arzneimittelforschung; 1989 Dec; 39(12):1522-5. PubMed ID: 2624598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
    Tymkewycz PM; Jones RL; Wilson NH; Marr CG
    Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature.
    Janssen LJ; Tazzeo T
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1060-6. PubMed ID: 12023538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
    Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
    Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.